Mehmet Özgür PINARBAŞLI, Ercan KAYA, Melek Kezban GÜRBÜZ, Hamdi ÇAKLI, Ali ALAİYE, Erkan Niyazi ÖZÜDOĞRU, Hülya KAÇAR

Karotis Cisim Tümörlerinde Klinik Deneyim: Görüntüleme Teknikleri Ve Cerrahi Yaklaşım

Amaç: Bu yazıda cerrahi olarak tedavi ettiğimiz karotis cisim tümörlü hastalarımıza ait sonuçlar değerlendirilerek, karotis cisim tümörlü hastalarda kullanılan görüntüleme teknikleri ve cerrahi tedavi yöntemleri tartışılmıştır. Yöntemler: Yazıda sunulan hastalara ait bilgiler hastane dosya kayıtlarının retrospektif olarak incelenmesi ile elde edilmiştir. Bulgular: Toplam 15 [14 kadın (%93,3); bir erkek (%6,7)] hastanın ortalama yaşı 52.47 ± 13.278(min: 25; maks: 69) dir. Sadece bir (%6,7) hastada bilateral tümör mevcuttur.On iki hastanın (%80) şikâyeti boyunda şişlik iken, geri kalan üç (%20) hastada tümör tesadüfen tespit edilmiştir. Shamblin sınıflandırmasına göre beş (%33,3) hasta Tip 1; dokuz (%60) hasta Tip 2; bir (%6,7) hasta ise Tip 3 olarak sınıflandırılmıştır.Patolojik spesmenlerden elde edilen bilgiye göre ortalama tümör çapı3.053 ± 0.9342 cm(min: 1,5 cm - maks: 4,7 cm) olup,tüm histopatolojik tanılar benignparagangliomadır. Hastaların tümü cerrahi olarak tedavi edilmiş olup, hiçbir hastanın carotis cisim tümörüne ilişkin daha öncesine ait herhangi bir tedavi öyküsü yoktur.Hastaların hiçbirinde postoperatif kalıcı önemli bir morbidite gelişmemiş olduğu tespit edilmiştir. Sonuç:Karotis cisim tümörleri cerrahi eksizyonla tedavi edilen, ancak karotis arter ile yakın ilişkisi nedeniyle cerrahisi özellikli tümörlerdir. Ameliyat öncesi hastaların titizlikle değerlendirilmesi cerrahinin başarısını artırır ve ameliyat sonrası komplikasyon oranını azaltır.

Clinical Experience In Carotid Body Tumors: Imaging Techniques And Surgical Approaches

Objective: In this article, the imaging techniques and surgical treatment methods used in patients with carotid bodytumors were discussed by evaluating the results of our patients with carotid body tumors that we treated surgically.Method: The information about the patients presented in the article was obtained by retrospectively examining thehospital file recordsResults: The mean age of 15 [14 females (93.3%); 1 male (6.7%)] patients was52.47 ± 13.278 (min: 25; max: 69).Onlyone (6.7% ) patient had bilateral tumor. The complaint of 12 (80%) patients was swelling in the neck of. In the remainingthree (20%) patients, the tumor in the neck was detected incidentally.According to the Shamblin classification; five(33.3%) patients were classified as Type 1, nine (60%) patients were classified as Type 2, and one (6.7%) patient wasclassified Type 3. The mean tumor diameter obtained was 3.053 ± 0.9342 cm (min:1,5 cm – max:4.7 cm),and allhistopathological diagnosis were benign paraganglioma. All patients were treated surgically, and no patient has anyprevious treatment history of carotid body tumor. No significant postoperative permanent morbidity was detected in anyof the patients.Conclusion: Carotid body tumors can be curative treated by surgical excision. However, because of its close relationshipwith the carotid artery, its surgery is special. Preoperatively meticulously evaluation of patients will increase the successof the surgery and reduce the postoperative complication rate.

PDF

___

1. Luna MA, Pineda-Daboin K. Cysts and Unknown Primary and Secondary Tumours of the Neck, and Neck Dissection. In: Cardesa A, SlootwegPJ,Gale N, Franchi A, editors. Pathology of the Head and Neck. Berlin: Springer Verlag Berlin and Heidelberg GmbH Co; 2016. p.273.
2. Başel H, Odabaşı D, Hazar A, Ekim H. Strategies at the treatment and diagnosis of carotid Body Tumors. TürkiyeKlinikleri J Cardiovasc Sci. 2009; 21:13-8.
3. Sanghvi VD, Chandawarkar RY. Carotid body tumors. J SurgOncol. 1993;54:190-2.
4. Sykes JM, Ossoff RH. Paragangliomas of the head and neck. OtolaryngolClin North Am. 1986; 19:755–67.
5. Shamblin WR, ReMine WH, Sheps SG, Harrison EG Jr. Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. Am J Surg. 1971; 122:732-9.
6. Arya S, Rao V, Juvekar S, Dcruz AK. Carotid body tumors: objective criteria to predict the Shamblin group on MR imaging. AJNR Am J Neuroradiol. 2008; 29: 1349-54.
7. Somasundar P, Krouse R, Hostetter R, Vaughan R, Covey T. Paragangliomas:a decade of clinical experience. J SurgOncol. 2000; 74:286-90.
8. Sajid MS, Hamilton G, Baker DM; Joint Vascular Research Group. A multicenter review of carotid body tumour management. Eur J VascEndovasc Surg. 2007; 34:127-30.
9. Zhang TH, Jiang WL, Li YL, Li B, Yamakawa T. Perioperative approach in the surgical management of carotid body tumors. Ann Vasc Surg. 2012; 26:775-82.
10. Netterville JL, Reilly KM, Robertson D, et al. Carotid body tumors: A review of 30 patients with 46 tumors. Laryngoscope. 1995; 105: 115– 26.
11. Kakkos SK, Reddy DJ, Shepard AD, et al. Contemporary presentation and evolution of management of neck paragangliomas. J Vasc Surg. 2009; 49: 1365–73.
12. Rao USV, Chatterjee S, Patil AA, Nayar RC. The “INT-EX Technique”: Internal to External Approach in Carotid Body Tumour Surgery. Indian J SurgOncol. 2017; 8:249-52.
13. Fruhmann J, Geigl JB, Konstantiniuk P, Cohnert TU. Paraganglioma of the carotid body: treatment strategy and SDH-gene mutations. Eur J VascEndovasc Surg. 2013; 45: 431–6.
14. Kruger AJ, Walker PJ, Foster WJ, et al. Important observations made managing carotid body tumors during a 25-year experience. J Vasc Surg. 2010; 52:1518-23.
15. Gad A, Sayed A, Elwan H, et al. Carotid body tumors: a review of 25 years’ experience in diagnosis and management of 56 tumors. Ann Vasc Dis. 2014; 7: 292-9.
16. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization Classification of Tumors.Pathology and genetics of head and neck tumours: Tumors of the paraganglionic system, chapter 8, 362-364; 2005.
17. Broes K, Vanderveken OM, Salgado R, et al. Atypical adenolymphoma and glomus caroticumtumour: a rare coincidence. B-ENT. 2012; 8:43-7.
18. Gnepp DR. Diagnostic Surgical Pathology of the Head and Neck, Second Edition. Saunders; 2009; p. 859-61.
19. Myssiorek D, Ferlito A, Silver CE, Rodrigo JP, Baysal BE, Fagan JJ, et al.Screening for familial paragangliomas. Oral Oncol. 2008; 44:532-7.
20. Álvarez-Morujo RJ, Ruiz MÁ, Serafini DP, et al. Management of multicentricparagangliomas: Review of 24 patients with 60 tumors. Head Neck. 2016; 38:267-76.